New role for GLP-1 drugs: Improving survival in people with severe psychiatric disorders
This editorial argues that GLP-1 receptor agonists could substantially improve healthspan and reduce premature mortality in people with serious mental illnesses by targeting cardiometabolic risk rather than psychiatric symptoms alone.…